Join Now

Yearly Archives: 2024

BioUtah and Coalition of Patient Advocates Talk PBM Reform with U.S. Reps. Blake Moore and Celeste Maloy

BioUtah’s VP for Government Affairs, Denise Bell, along with a coalition of patient advocates, life sciences executives, pharmacists, physicians, oncologists, and community organizations, held a lunch meeting with Representatives Blake Moore (R-UT) and Celeste Maloy (R-UT) October 1 to discuss the dangers of giving pharmacy benefit managers (PBMs) command over how much patients pay for […]

Posted in Policy News | Comments Off on BioUtah and Coalition of Patient Advocates Talk PBM Reform with U.S. Reps. Blake Moore and Celeste Maloy

BioUtah Member BBQ Recap

BioUtah’s annual membership appreciation BBQ was held yesterday at the Gateway’s Hidden Gem Patio. The event was a great way for the nearly 200 registrants to network with colleagues and make new connections. Prior to the BBQ, an executive reception was held, with several BioUtah Board members present. Also, in conjunction with the BBQ, the […]

Posted in BioUtah News | Comments Off on BioUtah Member BBQ Recap

UTAH REPS. CURTIS AND MOORE TOUR BIOMERIEUX

Representatives John Curtis (R-UT) and Blake Moore (R-UT) toured bioMérieux.

Posted in Policy News | Tagged | Comments Off on UTAH REPS. CURTIS AND MOORE TOUR BIOMERIEUX

BD Completes Acquisition of Critical Care from Edwards Lifesciences

BD announced it has completed the acquisition of Edwards Lifesciences’ Critical Care product group, which will be renamed as BD Advanced Patient Monitoring.

Posted in BioUtah News | Tagged , | Comments Off on BD Completes Acquisition of Critical Care from Edwards Lifesciences

Owlet Announces Expanded Availability of Medically-Certified Dream SockTM Across Europe

Owlet debuts new Dream Sock at Kind + Jugend 2024 and shares that the device will soon be available to even more parents across the globe.

Posted in BioUtah News | Tagged | Comments Off on Owlet Announces Expanded Availability of Medically-Certified Dream SockTM Across Europe

Recursion Announces Phase 2 Data of REC-994, a First-in-Disease Investigational Treatment for Symptomatic Cerebral Cavernous Malformation (CCM), has Met its Primary Endpoint of Safety and Tolerability

REC-994 also demonstrates encouraging trends in objective MRI-based exploratory efficacy measures at the highest dose and the company plans to advance development of REC-994 for the potential treatment of symptomatic CCM in subsequent studies.

Posted in BioUtah News | Tagged | Comments Off on Recursion Announces Phase 2 Data of REC-994, a First-in-Disease Investigational Treatment for Symptomatic Cerebral Cavernous Malformation (CCM), has Met its Primary Endpoint of Safety and Tolerability

FIRST ALL-FEMALE TAVI TRIAL SHOWS EXCELLENT OUTCOMES FOR WOMEN RECEIVING EDWARDS VALVES

Edwards Lifesciences announced the results from the RHEIA Trial.

Posted in BioUtah News | Tagged | Comments Off on FIRST ALL-FEMALE TAVI TRIAL SHOWS EXCELLENT OUTCOMES FOR WOMEN RECEIVING EDWARDS VALVES

Halia CEO, David Bearss, on Challenges Posed by FDA Project Optimus

Halia Therapeutics’ CEO, David Bearss, recently discussed the FDA’s Project Optimus in The Wall Street Journal.

Posted in BioUtah News | Tagged | Comments Off on Halia CEO, David Bearss, on Challenges Posed by FDA Project Optimus

ATL Technology Acquires Catheter Technologies Firm MDCM Solutions

SPRINGVILLE, UT, UNITED STATES, August 26, 2024 /EINPresswire.com/ — ATL Technology, a global leader in medical device development and manufacturing, announced today its acquisition of MDCM Solutions, a Minnesota manufacturing company specializing in complex catheter technologies used in the manufacture of minimally invasive medical devices. The newly acquired ATL Minnesota site will serve as a […]

Posted in BioUtah News | Comments Off on ATL Technology Acquires Catheter Technologies Firm MDCM Solutions

bioMeriéux, Curza, Present to Utah Life Sciences Innovation Caucus

Utah legislators on Wednesday, August 21, held a meeting of the Utah Life Sciences Innovation Caucus (ULSIC) at the state capitol. BioUtah President and CEO, Kelvyn Cullimore, introduced representatives from Salt Lake City-based bioMeriéux and Curza who presented before the ULSIC. Megan Kuehn, senior vice president of site operations for bioMeriéuxi, described the company’s development […]

Posted in Policy News | Comments Off on bioMeriéux, Curza, Present to Utah Life Sciences Innovation Caucus

VION Biosciences Acquires Industry Leader in Specialty Lipids and Lipid Nanoparticles, Echelon Biosciences

CHARLOTTESVILLE, Va.–(BUSINESS WIRE)–VION Biosciences, a life science platform company focused on specialty reagents in the life science research, diagnostic, and drug discovery space, announced the recent acquisition of Salt Lake City-based Echelon Biosciences, a trusted supplier of critical materials, notably lipid-based excipients, to its growing portfolio. This acquisition serves as the second investment under VION […]

Posted in BioUtah News | Comments Off on VION Biosciences Acquires Industry Leader in Specialty Lipids and Lipid Nanoparticles, Echelon Biosciences

Ultradent Announces Majority Stake in i-dental

Ultradent Products, Inc., a leading developer and manufacturer of high-tech dental materials, is announcing acquisition of Medicinos Linija UAB, known globally as “i-dental,” a renowned manufacturer and distributer of dental products headquartered in Siauliai, Lithuania. The addition of i-dental’s network and infrastructure will assist Ultradent’s ability to better serve dentists throughout the world. With i-dental […]

Posted in BioUtah News | Comments Off on Ultradent Announces Majority Stake in i-dental